Article of: Sarahb

Personalized Medicine for ASD

Our approach has expanded to analyze proteomic biomarkers as a way to identify ASD in younger children. Cell-El researchers envision

Biomarkers for ASD

We at Cell- El Ltd. are focusing our research on biomarkers in the blood, stool, and urine of children with

SC Treatment In Older Children

Cell-El researchers chose to broaden our biomarker analysis from 2–12 year-olds undergoing Stem Cell Therapy (SCT) to include children and

Mesenchymal Stem Cells

This article presents the rationale behind stem cell-based treatment for autism patients due to immune and nervous system abnormalities. This

Expanding Our Study

Cell El Ltd. has been studying the effects of stem cell treatment (SCT) on biomarkers in children with ASD ages

Diagnosis

Cell-El Ltd’s research, as described previously, focuses on biomarkers of immune dysfunction in ASD that are important to help us